patentgrepDocs Get an API key

C07K 16/3007

Carcino-embryonic antigens

Official title: {Carcino-embryonic Antigens}

C07K16/3007 (Carcino-embryonic antigens) appears on 474 US grants and 736 published applications in this corpus.

Search patents in C07K

Granted patents: 474
Published applications: 736
Assignees: 260
Inventors: 1,186
Latest grant: 29 Sep 2026

Filings by year

C07K 16/3007: granted patents and published applications per publication year
Year	Granted patents	Published applications
1982	4	0
1983	0	0
1984	3	0
1985	0	0
1986	1	0
1987	1	0
1988	1	0
1989	5	0
1990	2	0
1991	2	0
1992	2	0
1993	5	0
1994	0	0
1995	3	0
1996	5	0
1997	14	0
1998	13	0
1999	15	0
2000	7	0
2001	14	0
2002	16	14
2003	8	17
2004	4	16
2005	7	24
2006	5	13
2007	6	14
2008	9	19
2009	12	20
2010	14	17
2011	17	27
2012	16	21
2013	15	23
2014	21	30
2015	17	35
2016	30	39
2017	25	42
2018	16	29
2019	23	39
2020	16	39
2021	14	42
2022	20	51
2023	13	44
2024	15	55
2025	21	37
2026	17	29

By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.

Recent patents

Chimeric antigen receptor for treatment of cancer29 Sep 2026US 12,747,278 B2Industry-Academic Cooperation Foundation, Yonsei University
Anti-CEA antibody-exatecan analog conjugate and pharmaceutical use thereof8 Sep 2026US 12,728,168 B2Jiangsu Hengrui Medicine Co., Ltd.
Anti-CEACAM5 antibodies and conjugates and uses thereof8 Sep 2026US 12,729,239 B2Merck Patent GmbH
Molecules that bind to CD66e polypeptides11 Aug 2026US 12,703,760 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
Anti-CD40 binding molecules and bi-specific antibodies comprising such23 Jun 2026US 12,662,543 B2Lyvgen Biopharma Holdings Limited

Most cited

By later US patents